Related Experiment Video
Updated: Jan 3, 2026

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
Published on: February 23, 2024
Contrast Acuity With Different Colors in Parkinson's Disease
Harsh V Gupta1, Nan Zhang2, Erika Driver-Dunckley1
1Department of Neurology Mayo Clinic College of Medicine Scottsdale Arizona USA.
Parkinson's disease patients exhibit impaired color vision at both high and low contrasts. An iPad application shows potential as a simple biomarker for assessing color vision deficits in Parkinson's disease (PD).
Area of Science:
- Ophthalmology
- Neurology
- Medical Technology
Background:
- Abnormal color vision and contrast acuity significantly impact daily life.
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function and potentially sensory perception.
- Assessing visual function is crucial for understanding the multifaceted effects of PD.
Purpose of the Study:
- To evaluate color visual acuity at high and low contrast in individuals with Parkinson's disease (PD) and control groups.
- To assess the utility of an iPad application for measuring color vision in PD.
- To investigate potential differences in color perception between PD patients and healthy controls.
Main Methods:
- Color visual acuity was tested using the Variable Contrast Acuity Chart on an iPad.
- Five colors (red, green, blue, yellow, black) were assessed at low (2.5%) and high (100%) contrast.
- A numerical score was assigned based on correctly identified colors, with statistical analysis adjusting for age and sex.
Main Results:
- Parkinson's disease patients demonstrated significantly lower color vision scores compared to controls at both high and low contrasts (except for yellow at low contrast).
- The largest effect size was observed for yellow at high contrast.
- The iPad application showed high specificity (97%) and positive predictive value (92%) for detecting color vision deficits in PD.
Conclusions:
- An iPad-based application may serve as a user-friendly biomarker for color vision assessment in Parkinson's disease.
- Further research is warranted to establish disease specificity and explore its role in monitoring disease progression and treatment.
- Investigating prodromal PD detection using this visual biomarker is a potential future direction.
More Related Videos
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Photoreceptors and Visual Pathways
Color Vision
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Anatomy of the Eyeball
Visual Agnosia